EIF2AK4 and Hepatic steatosis: In summary, our study indicates that genetic and pharmacological inhibition of GCN2 alleviates hyperglycemia and insulin resistance in T2D mice by regulating hepatic glucose metabolism and attenuating hepatic steatosis and oxidative stress.